GLYRX-PF .2 mg/mL
glycopyrrolate · INJECTION, SOLUTION · Exela Pharma Sciences, LLC
No Recall History
Plain English
GLYRX-PF is a injection, solution containing glycopyrrolate at .2 mg/mL, taken intramuscular. Manufactured by Exela Pharma Sciences, LLC.
Key Facts
- Brand Name
- GLYRX-PF
- Generic Name
- glycopyrrolate
- NDC Code (Product)
51754-6001- Manufacturer
- Exela Pharma Sciences, LLC
- Strength
- .2 mg/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR, INTRAVENOUS
- Marketing Status
- Application #
- NDA210997
- Marketing Start
- 08/01/2018
Recall History
No Recall HistoryFrequently Asked Questions
What is GLYRX-PF used for?
GLYRX-PF contains glycopyrrolate. It is a injection, solution taken intramuscular. Consult your doctor for specific uses.
Is GLYRX-PF a controlled substance?
GLYRX-PF is not classified as a controlled substance by the DEA.
What is the generic name for GLYRX-PF?
The generic name for GLYRX-PF is glycopyrrolate. There are 12 other brand versions of glycopyrrolate.
What is the NDC code for GLYRX-PF .2 mg/mL?
The NDC (National Drug Code) for GLYRX-PF .2 mg/mL is 51754-6001, listed by Exela Pharma Sciences, LLC.
Other Glycopyrrolate Brands
See all →- Glycopyrrolate1 mg/172162-1477
- Glycopyrrolate.2 mg/mL0517-4602
- Glycopyrrolate.2 mg/mL0517-4605
- GLYCOPYRROLATE.2 mg/mL75834-196
- Glycopyrrolate.2 mg/mL84549-203
- Glycopyrrolate4 mg/20mL0781-3831
- GLYCOPYRROLATE1 mg/113107-014
- GLYCOPYRROLATE1 mg/115955-305
- Glycopyrrolate1 mg/116571-743
- Glycopyrrolate2 mg/116571-744
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)